New appendix criteria open for a broader concept of chronic migraine

J. Olesen, M. G. Bousser, H. C. Diener, D. Dodick, M. First, P. J. Goadsby, H. Göbel, M. J A Lainez, J. W. Lance, R. B. Lipton, G. Nappi, F. Sakai, J. Schoenen, S. D. Silberstein, T. J. Steiner

Research output: Contribution to journalArticle

741 Citations (Scopus)

Abstract

After the introduction of chronic migraine and medication overuse headache as diagnostic entities in The International Classification of Headache Disorders, Second Edition, ICHD-2, it has been shown that very few patients fit into the diagnostic criteria for chronic migraine (CM). The system of being able to use CM and the medication overuse headache (MOH) diagnosis only after discontinuation of overuse has proven highly unpractical and new data have suggested a much more liberal use of these diagnoses. The International Headache Classification Committee has, therefore, worked out the more inclusive criteria for CM and MOH presented in this paper. These criteria are included in the appendix of ICHD-2 and are meant primarily for further scientific evaluation but may be used already now for inclusion into drug trials, etc. It is now recommended that the MOH diagnosis should no longer request improvement after discontinuation of medication overuse but should be given to patients if they have a primary headache plus ongoing medication overuse. The latter is defined as previously, i.e. 10 days or more of intake of triptans, ergot alkaloids mixed analgesics or opioids and 15 days or more of analgesics/NSAIDs or the combined use of more than one substance. If these new criteria for CM and MOH prove useful in future testing, the plan is to include them in a future revised version of ICHD-2.

Original languageEnglish
Pages (from-to)742-746
Number of pages5
JournalCephalalgia
Volume26
Issue number6
DOIs
Publication statusPublished - Jun 2006

Fingerprint

Secondary Headache Disorders
Migraine Disorders
Headache
Ergot Alkaloids
Tryptamines
Headache Disorders
Non-Steroidal Anti-Inflammatory Agents
Opioid Analgesics
Analgesics
Pharmaceutical Preparations

Keywords

  • Argot alkaloids
  • Disease classification
  • Drug dependency
  • Migraine
  • Opioids
  • Primary headaches
  • Triptans

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Olesen, J., Bousser, M. G., Diener, H. C., Dodick, D., First, M., Goadsby, P. J., ... Steiner, T. J. (2006). New appendix criteria open for a broader concept of chronic migraine. Cephalalgia, 26(6), 742-746. https://doi.org/10.1111/j.1468-2982.2006.01172.x

New appendix criteria open for a broader concept of chronic migraine. / Olesen, J.; Bousser, M. G.; Diener, H. C.; Dodick, D.; First, M.; Goadsby, P. J.; Göbel, H.; Lainez, M. J A; Lance, J. W.; Lipton, R. B.; Nappi, G.; Sakai, F.; Schoenen, J.; Silberstein, S. D.; Steiner, T. J.

In: Cephalalgia, Vol. 26, No. 6, 06.2006, p. 742-746.

Research output: Contribution to journalArticle

Olesen, J, Bousser, MG, Diener, HC, Dodick, D, First, M, Goadsby, PJ, Göbel, H, Lainez, MJA, Lance, JW, Lipton, RB, Nappi, G, Sakai, F, Schoenen, J, Silberstein, SD & Steiner, TJ 2006, 'New appendix criteria open for a broader concept of chronic migraine', Cephalalgia, vol. 26, no. 6, pp. 742-746. https://doi.org/10.1111/j.1468-2982.2006.01172.x
Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 Jun;26(6):742-746. https://doi.org/10.1111/j.1468-2982.2006.01172.x
Olesen, J. ; Bousser, M. G. ; Diener, H. C. ; Dodick, D. ; First, M. ; Goadsby, P. J. ; Göbel, H. ; Lainez, M. J A ; Lance, J. W. ; Lipton, R. B. ; Nappi, G. ; Sakai, F. ; Schoenen, J. ; Silberstein, S. D. ; Steiner, T. J. / New appendix criteria open for a broader concept of chronic migraine. In: Cephalalgia. 2006 ; Vol. 26, No. 6. pp. 742-746.
@article{ff92d657eb7a4bef9839993fa2d89d5f,
title = "New appendix criteria open for a broader concept of chronic migraine",
abstract = "After the introduction of chronic migraine and medication overuse headache as diagnostic entities in The International Classification of Headache Disorders, Second Edition, ICHD-2, it has been shown that very few patients fit into the diagnostic criteria for chronic migraine (CM). The system of being able to use CM and the medication overuse headache (MOH) diagnosis only after discontinuation of overuse has proven highly unpractical and new data have suggested a much more liberal use of these diagnoses. The International Headache Classification Committee has, therefore, worked out the more inclusive criteria for CM and MOH presented in this paper. These criteria are included in the appendix of ICHD-2 and are meant primarily for further scientific evaluation but may be used already now for inclusion into drug trials, etc. It is now recommended that the MOH diagnosis should no longer request improvement after discontinuation of medication overuse but should be given to patients if they have a primary headache plus ongoing medication overuse. The latter is defined as previously, i.e. 10 days or more of intake of triptans, ergot alkaloids mixed analgesics or opioids and 15 days or more of analgesics/NSAIDs or the combined use of more than one substance. If these new criteria for CM and MOH prove useful in future testing, the plan is to include them in a future revised version of ICHD-2.",
keywords = "Argot alkaloids, Disease classification, Drug dependency, Migraine, Opioids, Primary headaches, Triptans",
author = "J. Olesen and Bousser, {M. G.} and Diener, {H. C.} and D. Dodick and M. First and Goadsby, {P. J.} and H. G{\"o}bel and Lainez, {M. J A} and Lance, {J. W.} and Lipton, {R. B.} and G. Nappi and F. Sakai and J. Schoenen and Silberstein, {S. D.} and Steiner, {T. J.}",
year = "2006",
month = "6",
doi = "10.1111/j.1468-2982.2006.01172.x",
language = "English",
volume = "26",
pages = "742--746",
journal = "Cephalalgia",
issn = "0333-1024",
publisher = "SAGE Publications Ltd",
number = "6",

}

TY - JOUR

T1 - New appendix criteria open for a broader concept of chronic migraine

AU - Olesen, J.

AU - Bousser, M. G.

AU - Diener, H. C.

AU - Dodick, D.

AU - First, M.

AU - Goadsby, P. J.

AU - Göbel, H.

AU - Lainez, M. J A

AU - Lance, J. W.

AU - Lipton, R. B.

AU - Nappi, G.

AU - Sakai, F.

AU - Schoenen, J.

AU - Silberstein, S. D.

AU - Steiner, T. J.

PY - 2006/6

Y1 - 2006/6

N2 - After the introduction of chronic migraine and medication overuse headache as diagnostic entities in The International Classification of Headache Disorders, Second Edition, ICHD-2, it has been shown that very few patients fit into the diagnostic criteria for chronic migraine (CM). The system of being able to use CM and the medication overuse headache (MOH) diagnosis only after discontinuation of overuse has proven highly unpractical and new data have suggested a much more liberal use of these diagnoses. The International Headache Classification Committee has, therefore, worked out the more inclusive criteria for CM and MOH presented in this paper. These criteria are included in the appendix of ICHD-2 and are meant primarily for further scientific evaluation but may be used already now for inclusion into drug trials, etc. It is now recommended that the MOH diagnosis should no longer request improvement after discontinuation of medication overuse but should be given to patients if they have a primary headache plus ongoing medication overuse. The latter is defined as previously, i.e. 10 days or more of intake of triptans, ergot alkaloids mixed analgesics or opioids and 15 days or more of analgesics/NSAIDs or the combined use of more than one substance. If these new criteria for CM and MOH prove useful in future testing, the plan is to include them in a future revised version of ICHD-2.

AB - After the introduction of chronic migraine and medication overuse headache as diagnostic entities in The International Classification of Headache Disorders, Second Edition, ICHD-2, it has been shown that very few patients fit into the diagnostic criteria for chronic migraine (CM). The system of being able to use CM and the medication overuse headache (MOH) diagnosis only after discontinuation of overuse has proven highly unpractical and new data have suggested a much more liberal use of these diagnoses. The International Headache Classification Committee has, therefore, worked out the more inclusive criteria for CM and MOH presented in this paper. These criteria are included in the appendix of ICHD-2 and are meant primarily for further scientific evaluation but may be used already now for inclusion into drug trials, etc. It is now recommended that the MOH diagnosis should no longer request improvement after discontinuation of medication overuse but should be given to patients if they have a primary headache plus ongoing medication overuse. The latter is defined as previously, i.e. 10 days or more of intake of triptans, ergot alkaloids mixed analgesics or opioids and 15 days or more of analgesics/NSAIDs or the combined use of more than one substance. If these new criteria for CM and MOH prove useful in future testing, the plan is to include them in a future revised version of ICHD-2.

KW - Argot alkaloids

KW - Disease classification

KW - Drug dependency

KW - Migraine

KW - Opioids

KW - Primary headaches

KW - Triptans

UR - http://www.scopus.com/inward/record.url?scp=33745184401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745184401&partnerID=8YFLogxK

U2 - 10.1111/j.1468-2982.2006.01172.x

DO - 10.1111/j.1468-2982.2006.01172.x

M3 - Article

C2 - 16686915

AN - SCOPUS:33745184401

VL - 26

SP - 742

EP - 746

JO - Cephalalgia

JF - Cephalalgia

SN - 0333-1024

IS - 6

ER -